"10.1371_journal.pone.0035582","plos one","2012-04-25T00:00:00Z","Be√°ta Flachner; Zsolt L√∂rincz; Angelo Carotti; Orazio Nicolotti; Praveena Kuchipudi; Nikita Remez; Ferran Sanz; J√≥zsef T√≥v√°ri; Mikl√≥s J Szab√≥; B√©la Bert√≥k; S√°ndor Cseh; Jordi Mestres; Gy√∂rgy Dorm√°n","TargetEx, Dunakeszi, Hungary; Medicinal Chemistry Department, University of Bari ‚ÄúAldo Moro‚Äù, Bari, Italy; IMIM ‚Ä Hospital del Mar Research Institute and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; National Institute of Oncology, Budapest, Hungary; AMRI Hungary Zrt., Budapest, Hungary","Conceived and designed the experiments: AC FS BB SC JM GD. Performed the experiments: BF ZL JT SC. Analyzed the data: JM GD. Wrote the paper: JM GD. Performed the calculations: ON PK NR MJS. All authors read and approved the final manuscript.","The authors have read the journals policy and have the following conflicts: Be√°ta Flachner, Zsolt L√∂rincz, S√°ndor Cseh, and Gy√∂rgy Dorm√°n are full-time paid employees of TargetEx, Dunakeszi, Hungary, and Mikl√≥s J. Szab√≥ and B√©la Bert√≥k are full-time employees of AMRI Hungary Zrt., Budapest, Hungary. Jordi Mestres is President of Chemotargets SL. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Be√°ta Flachner","B√F",13,TRUE,6,4,2,2,TRUE,FALSE,FALSE,0,NA,FALSE
